Masimo Corporation

NasdaqGS:MASI Stock Report

Market Cap: US$7.7b

Masimo Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Katie Szyman

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1yr
CEO ownershipn/a
Management average tenure1yr
Board average tenure1.3yrs

Recent management updates

Recent updates

Is Masimo Corporation (NASDAQ:MASI) Potentially Undervalued?

Sep 12
Is Masimo Corporation (NASDAQ:MASI) Potentially Undervalued?

Calculating The Fair Value Of Masimo Corporation (NASDAQ:MASI)

Aug 01
Calculating The Fair Value Of Masimo Corporation (NASDAQ:MASI)

Masimo Corporation: A Much Cleaner Picture

Jun 23

Is Masimo (NASDAQ:MASI) Using Too Much Debt?

Jun 19
Is Masimo (NASDAQ:MASI) Using Too Much Debt?

Is It Time To Consider Buying Masimo Corporation (NASDAQ:MASI)?

May 29
Is It Time To Consider Buying Masimo Corporation (NASDAQ:MASI)?

Masimo: Priced Dearly Given Uncertainty

Apr 25

Pinning Down Masimo Corporation's (NASDAQ:MASI) P/S Is Difficult Right Now

Apr 24
Pinning Down Masimo Corporation's (NASDAQ:MASI) P/S Is Difficult Right Now

An Intrinsic Calculation For Masimo Corporation (NASDAQ:MASI) Suggests It's 34% Undervalued

Feb 17
An Intrinsic Calculation For Masimo Corporation (NASDAQ:MASI) Suggests It's 34% Undervalued

At US$178, Is Masimo Corporation (NASDAQ:MASI) Worth Looking At Closely?

Jan 30
At US$178, Is Masimo Corporation (NASDAQ:MASI) Worth Looking At Closely?

Masimo: A Stellar Performance After The Dust Has Settled

Dec 11

Masimo Corporation: Too Much Uncertainty For Now

Sep 25
User avatar

Sensors Surge And Decisive Shifts Set To Soar In Healthcare Triumph

Increased hospital admissions and successful hospital conversions to Masimo products are anticipated to continue driving healthcare revenue growth.

Masimo: Promising Developments

May 12

CEO

Katie Szyman (58 yo)

1yr
Tenure

Ms. Catherine M. Szyman, also known as Katie, serves as Chief Executive Officer at Masimo Corporation since February 12, 2025. She is an Independent Director of Inari Medical, Inc. since November 25, 2019....


Leadership Team

NamePositionTenureCompensationOwnership
Catherine Szyman
CEO & Director1yrno datano data
Micah Young
Chief Financial Officer8.3yrsUS$8.12m0.032%
$ 2.5m
Anand Sampath
Executive Vice President of Operationsless than a yearUS$1.97mno data
Paul Hataishi
Senior VP & Chief Accounting Officer2.9yrsno datano data
Yongsam Lee
Executive VP & Chief Information Officer23.8yrsUS$1.49mno data
Steven Barker
Chairman of Scientific Advisory Board & Chief Science Officer10.8yrsUS$139.56kno data
Matthew Brinckman
Senior Vice President of FP&A and Investor Relationsno datano datano data
Charles Dadswell
Executive Vice President & General Counsel1yrno datano data
Tim Benner
Chief Marketing & Strategy Officerless than a yearno datano data
Elisabeth Hellmann
Chief Human Resources Officerless than a yearno datano data
Ammar Al-Ali
Chief of Engineeringless than a yearUS$992.45kno data
Huimin Wang
President of Japan & Asia Pacificless than a yearno datano data
1.0yrs
Average Tenure
59yo
Average Age

Experienced Management: MASI's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Catherine Szyman
CEO & Directorless than a yearno datano data
Steven Barker
Chairman of Scientific Advisory Board & Chief Science Officerno dataUS$139.56kno data
Christopher Chavez
Director1.3yrsno datano data
Craig Reynolds
Lead Independent Director11.8yrsUS$330.41k0.034%
$ 2.6m
Wendy Lane
Independent Director1.3yrsUS$215.17k0.0026%
$ 197.0k
Timothy Scannell
Independent Director1.3yrsUS$215.97k0.0026%
$ 197.0k
Darlene J. Solomon
Independent Director1.3yrsUS$226.01k0.0033%
$ 255.2k
Quentin Koffey
Independent Vice-Chairman2.6yrsUS$300.89k0.0046%
$ 350.3k
Michelle Brennan
Independent Chairman2.6yrsUS$2.62m0.014%
$ 1.0m
1.3yrs
Average Tenure
66yo
Average Age

Experienced Board: MASI's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/21 10:44
End of Day Share Price 2026/01/21 00:00
Earnings2025/09/27
Annual Earnings2024/12/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Masimo Corporation is covered by 23 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael PolarkBaird
Charley JonesBarrington Research Associates, Inc.
Ravi MisraBerenberg